Table 1 Demographic and Disease Characteristics, Patient Survey Data
From: Severity and management of psoriasis within primary care
Characteristic | (n = 905) |
|---|---|
Sex, n (%) | |
Male/female | 436/469 (48.2/51.8) |
Age | |
Mean (SD) | 54.53 (16.07) |
Patient care, n (%) | |
Primary care only (general practitioner) | 688 (76.0) |
Specialista | 217 (24.0) |
DLQI | |
Mean (SD) | 6.143 (6.198) |
Median | 4.0 |
Range | 0–29 |
DLQI category: effect on patient’s life, n (%) | |
No effect (0–1) | 249 (27.5) |
Small effect (2–5) | 265 (29.3) |
Moderate effect (6–10) | 204 (22.5) |
Very large effect (11–20) | 150 (16.6) |
Extremely large effect (21–30) | 37 (4.1) |
SAPASI | |
Mean (SD) | 6.369 (5.612) |
Median | 6.00 |
Range | 0–59.76 |
Areas involved, n (%) | |
Limbs | 669 (73.9) |
Scalp | 563 (62.2) |
Trunk | 432 (47.7) |
Hands | 324 (35.8) |
Feet | 247 (27.3) |
Face | 247 (27.3) |
Nails | 288 (31.8) |
Genital area | 167 (18.5) |
Plaques on palms of hands | 112 (12.4) |
Plaques on soles of feet | 101 (11.2) |
Current treatments for psoriasis, n (%) | |
No treatment | 156 (17.2) |
Topical treatment onlyb | 587 (64.9) |
Oral drugs | 68 (7.5) |
Methotrexate | 31 (3.4) |
Phototherapy | 54 (6.0) |
Biologics | 26 (2.9) |
Other treatments (non-prescribed) | 29 (3.2) |
Missing | 14 (1.5) |
Presence of comorbidities, n (%) | |
Cardiovascular disease (such as angina, heart problems, high blood pressure) | 247 (27.3) |
High cholesterol | 158 (17.5) |
Depression/anxiety problems | 152 (16.8) |
Chest/respiratory problems (eg, asthma, bronchitis, COPD) | 111 (12.3) |
Diabetes | 81 (9.0) |
Obesityc | 77 (8.5) |
Cerebrovascular disease (such as stroke, haemorrhage, aneurysm) | 28 (3.1) |
Cancer (excluding skin cancer) | 25 (2.8) |
Liver disease | 9 (1.0) |